KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biomarin Pharmaceutical (BMRN) Times Interest Earned (2017 - 2025)

Biomarin Pharmaceutical (BMRN) has disclosed Times Interest Earned for 16 consecutive years, with -$16.06 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Times Interest Earned fell 125.64% year-over-year to -$16.06, compared with a TTM value of $37.57 through Dec 2025, down 1.72%, and an annual FY2025 reading of $37.57, down 1.72% over the prior year.
  • Times Interest Earned was -$16.06 for Q4 2025 at Biomarin Pharmaceutical, up from -$18.1 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $103.35 in Q2 2025 and bottomed at -$18.1 in Q3 2025.
  • Average Times Interest Earned over 5 years is $18.86, with a median of $9.11 recorded in 2023.
  • The sharpest move saw Times Interest Earned surged 1663.71% in 2023, then tumbled 147.18% in 2025.
  • Year by year, Times Interest Earned stood at -$17.13 in 2021, then surged by 78.93% to -$3.61 in 2022, then soared by 290.34% to $6.87 in 2023, then soared by 811.64% to $62.63 in 2024, then tumbled by 125.64% to -$16.06 in 2025.
  • Business Quant data shows Times Interest Earned for BMRN at -$16.06 in Q4 2025, -$18.1 in Q3 2025, and $103.35 in Q2 2025.